2014 Newsletter Archive

January 2014

Alzheimer’s Advocate vol. 70

FDA Fares Well in FY 2014 Appropriations

NAPA Advisory Council to Hold First Meeting of 2014

Academy of Radiology Research Sets Date for Postponed Conference on Brain Imaging Advances

ACT-AD Member Hosts 8th Drug Discovery for Neurodegeneration Conference

February 2014

Alzheimer’s Advocate vol. 71

FDA and IOM Examine Risk-Benefit Communication

Accelerating Medicines Partnerships Launches to Speed Drug Development

Academy of Radiology Research Holds Conference on Brain Imaging Advances

Beginning with the End in Mind – Study Endpoints: Targeting Patient-Centered Outcomes

March 2014

Alzheimer’s Advocate vol. 72

FDA to Examine Inclusion of Subpopulations in Clinical Trials

Health Affairs: The Long Reach of Alzheimer’s Disease

NIBIB Director to Host Seminar on Technological Advances

ACT-AD Chair to Screen Pocket Films at French Embassy

GE Launches MIND App for Patients and Caregivers

April 2014

Alzheimer’s Advocate vol. 73

ACT-AD Member Announces $8.7 Million in Research Grants for Alzheimer’s and Vision Diseases

Coalition Sponsors Health Affairs Special Issue on Alzheimer’s Disease

ACT-AD Chair Holds Successful Screening of ‘Pocket Films’ at French Embassy

CMS National Partnership to Improve Dementia Care in Nursing Homes Holds Call on May 20th

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6th

May 2014

Alzheimer’s Advocate vol. 74

2014 National Alzheimer’s Disease Plan Released

Alzheimer’s Foundation of America Releases Report

Aging Research at the National Institute on Aging Briefing June 6th

Neuroscience and Aging Discussion September 10th in Washington, D.C.th

Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6th

June 2014

Alzheimer’s Advocate vol. 75

NIA: Volunteers Requested for Alzheimer’s Clinical Trials

Scientists Map Path of Alzheimer’s-Linked Brain Cells in Mouse Models

Project Lifesaver International Holds Annual Conference This August

ACT-AD Responds to 21st Century Cures White Paper

Study Reveals Possible Novel Therapy for Alzheimer’s

Memory in Old Age May Be Affected by History of High Blood Pressure

$4.5 Billion Brain Research Report Receives Positive Response from NIH

Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6th

July 2014

Alzheimer’s Advocate vol. 76

Webinar Series on Alzheimer’s Disease and Related Dementias Launches

2013-2014 Alzheimer’s Disease Progress Report Now Available

National Memory Screening Day Is November 18

Path to Fund Development of Alzheimer’s Drugs Suggested

NIH Sends Out Call for Participants for A4 Clinical Trial

2014 Alzheimer’s Association International Conference Resources Available

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6

August 2014

Alzheimer’s Advocate vol. 77

ACT-AD FDA/AD Allies Meeting Proceedings to Be Featured inExpert Review of Neurotherapeutics

FDA PDUFA V Plan on Demographic Data Released

AFA Caregiver Conference Set for September 12

Alzheimer’s Prevention Registry Adds 40,000th Volunteer

AARP and ReACT Host Caregiver Event, September 29

Study Shows Link between DNA Methylation and Alzheimer’s

Researchers Find Area in Brain Associated with Contextual Memories

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6


September 2014

Alzheimer’s Advocate vol. 78

Positive Trial Results Reported for Treatment of Agitation

RSVP for 7th Annual FDA/Alzheimer’s Disease Allies Meeting

NIA Offers Alzheimer’s Medications Fact Sheet

2014 World Alzheimer’s Day Recognized

Bexarotene’s Effect on Alzheimer’s May Be Dependent on Disease Severity

Study Offers New Insights of Buildup of Beta-Amyloid Plaques in Brain


October 2014

Alzheimer’s Advocate vol. 79

RSVP for 7th Annual FDA/Alzheimer’s Disease Allies Meeting

APECS Study Seeks Participants

Scientists Create ‘Alzheimer’s in a Dish’

Registration Now Open for 2015 NIH Alzheimer’s Disease Research Summit

Alzheimer’s May Erase Memories, But Emotions Often Remain, Finds Study

MRI Technique Reveals Cognitive Decline before Symptoms Appear

Researchers Use Large Data Collection to Find New Gene Linked to AD


November 2014

Alzheimer’s Advocate vol. 80

ACT-AD Holds 7th Annual FDA/Alzheimer’s Disease Allies Meeting

Updates of Note from NIH, CDC, Other Agencies

Organization Releases Trend Report of Antipsychotic Drug Use

New Neurological Disorder Has Links to Alzheimer’s

Conference on Drug Discovery for Neurodegeneration Set for March 1-3, 2015

Study Finds Tau, Not Amyloid-Beta Plaque,Causes Neuron Death

Growth of Older Population to Drive Higher Alzheimer’s Costs


December 2014

Alzheimer’s Advocate vol. 81

​ACT-AD Submits Comments on FDA PDUFA V Initiative

ACT-AD Offers Insights on Aging Well in 21st Century

ACT-AD Science Advisory Board Member Gives Keynote Address at CTAD Conference

Psoriasis Drug Could Stimulate Alzheimer’s-Fighting Enzyme

NIH Issues Draft Policy Promoting IRBs

Study: Midlife Diabetes Accelerates Rate of Cognitive Decline

Keeping Microglia ‘On the Job’ Could Ward Off Alzheimer’s